Study Title
Concurrent EUS-guided Intra-tumour Injection of OncoSil (32P) With Chemotherapy in Locally Advanced Pancreatic Carcinoma.
Study Details
Description:
The outcomes of concurrent EUS-guided intra-tumour injection of P-32 microparticles (OncoSil; OncoSil Medical, Australia) with chemotherapy in locally advanced pancreatic carcinoma in the local population is uncertain. The aim of the current study is to assess efficacy and safety of the intervention in the local population. We hypothesis that the intervention is safe and useful for tumour downstaging.
Sponsor:
Chinese University of Hong Kong
Contacts:
Anthony YB Teoh, FRCSEd (Principal Investigator)anthonyteoh@surgery.cuhk.edu.hk
35052956
Zero Chungzerochung@surgery.cuhk.edu.hk
35052956
Government Study Link:
NCT05131776 - Click here to see study onClinicalTrials.gov